(Q35754699)

English

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer

scientific article published on April 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Thomas E Yankeelov

14

object named as

Thomas E Yankeelov

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

author name string

Xia Li

1

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Richard G Abramson

2

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Lori R Arlinghaus

3

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Hakmook Kang

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Anuradha Bapsi Chakravarthy

5

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Vandana G Abramson

6

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Jaime Farley

7

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ingrid A Mayer

8

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Mark C Kelley

9

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ingrid M Meszoely

10

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Julie Means-Powell

11

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Ana M Grau

12

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Melinda Sanders

13

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

publication date

1 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Investigative Radiology

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

195-204

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

2 October 2017

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

12 July 2018

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

25 September 2018

Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

25 September 2018

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

25 September 2018

Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

25 September 2018

Multimodality image registration by maximization of mutual information.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4471951

25 September 2018

Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiparametric imaging of tumor response to therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of Clinicopathologic Response of Breast Cancer to Primary Chemotherapy at Contrast-enhanced MR Imaging: Initial Clinical Results

1 reference

https://pubmed.ncbi.nlm.nih.gov/25360603

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/RLI.0000000000000100

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35754699&oldid=1966906569"